Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Careteq Ltd. ( (AU:CTQ) ).
Careteq Limited has issued 20,432,192 new fully paid ordinary shares at an issue price of $0.01 per share, expanding its capital base without providing a prospectus or other disclosure document to investors. The company confirmed it is compliant with its financial reporting and continuous disclosure obligations and stated there is no excluded information that would require additional disclosure under the Corporations Act.
The share issue, conducted under the Corporations Act’s secondary trading provisions, is designed to facilitate on-market trading of the new stock without further regulatory disclosure. This move strengthens Careteq’s balance sheet and supports its ongoing operations in the medication management technology space, while signalling to investors that it remains in good standing with corporate governance and reporting requirements.
The most recent analyst rating on (AU:CTQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Careteq Ltd. stock, see the AU:CTQ Stock Forecast page.
More about Careteq Ltd.
Careteq Limited is an Australian healthtech company specialising in innovative medication management solutions for the aged-care and community healthcare sectors. Through its Embedded Health Solutions platform, it delivers Residential Medication Management Reviews, while its HMR Referrals platform streamlines Home Medicines Reviews for patients in the community.
Average Trading Volume: 578,509
Technical Sentiment Signal: Sell
See more insights into CTQ stock on TipRanks’ Stock Analysis page.

